Table 4 Various measurements in patients and controls as means (SD) and number of pathological values
| Â | Â | Â | Number with pathological values | |
|---|---|---|---|---|
| Â | Patients | Controls | Patient group | Controls/Mi controls |
Pulse | 78 (14) | 72 (12)* | 2 >100 beats/min (1 CTS, 1 Mi) | 0/0 |
Systolic blood pressure | 120 (15) | 112 (10)†| 1 >150 mmHg (stroke) | 0/0 |
Diastolic blood pressure | 74 (10) | 72 (8) | 1 >95 mmHg (Mi) | 0/0 |
Hemoglobin | 12.9 (1.1) | 12.3 (1.1)†| 4 low (all Mi) | 10/9 low |
Platelet count | 250 (74) | 249 (63) | 1 low (MS), 2 high (stroke, Mi) | 2 low, 1 high/2 low, 1 high |
ESR | 20 (19) | 16 (12) | 13 high (2 CTS, 1 stroke, 1 PS, 9 Mi) | 9/8 high |
APPT | 27.7 (5.0) | 27.6 (2.2) | 2 high (stroke, Mi) | 0/0 |
Fibrinogen | 3.8 (1.3) | 3.5 (0.9) | 12 high (1 stroke, 1 PS, 2 CTS, 8 Mi) | 8/7 high |
Antithrombin 3 | 112 (15) | 108 (15) | 1 low (Mi) | 3/3 low |
Cholesterol | 5.4 (1.2) | 5.2 (1.3) | 5 high (1 CTS, 4 Mi) | 3/3 high |
Triglycerides | 1.5 (1.1) | 1.1 (0.8) | 6 high (1 CTS, 5 Mi) | 3/3 high |
Glucose | 4.6 (0.5) | 5.0 (0.9)* | 0 | 3/2 high |
Anticardiolipin ab IgG | 0.16 (0.4) | 0.03 (0.2) | 7 positive (1 stroke, 6 Mi) | 1/1 positive |
Anticardiolipin ab IgM | 0.14 (0.4) | 0.05 (0.2) | 4 positive (1 stroke, 3 Mi) | 3/2 positive |
Antinuclear antigen | 0.11 (0.3) | 0.11 (0.3) | 5 positive (1 stroke, 4 Mi) | 4/3 positive |
Lupus anticoagulant | 0.3 (0.2) | 0.0 (0) | 1 positive (stroke) | 1/1 positive |
Lues serology | 0.3 (0.2) | 0.0 (0) | 1 positive (stroke) | 0/0 |
Homocysteine | 9.9 (6.0) | 9.3 (7.3) | 6 high (1 stroke, 5 Mi) | 1/0 high |
Protein C | 113 (20) | 108 (15) | 0 | 0/0 |
Protein S | 71 (23) | 68 (15) | 16 low (1 stroke, 2 CTS, 13 Mi) | 18/15 low |